questionsmedicales.fr
Administration des services de santé
Organisation et administration
Gestion du risque
Gestion du risque : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Gestion du risque : Questions médicales les plus fréquentes",
"headline": "Gestion du risque : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Gestion du risque : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-14",
"dateModified": "2025-05-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Gestion du risque"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Organisation et administration",
"url": "https://questionsmedicales.fr/mesh/D009934",
"about": {
"@type": "MedicalCondition",
"name": "Organisation et administration",
"code": {
"@type": "MedicalCode",
"code": "D009934",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Participation aux risques financiers",
"alternateName": "Risk Sharing, Financial",
"url": "https://questionsmedicales.fr/mesh/D020414",
"about": {
"@type": "MedicalCondition",
"name": "Participation aux risques financiers",
"code": {
"@type": "MedicalCode",
"code": "D020414",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N04.452.871.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Gestion du risque",
"alternateName": "Risk Management",
"code": {
"@type": "MedicalCode",
"code": "D012308",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Hal S Wortzel",
"url": "https://questionsmedicales.fr/author/Hal%20S%20Wortzel",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Sean M Barnes",
"url": "https://questionsmedicales.fr/author/Sean%20M%20Barnes",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Bridget B Matarazzo",
"url": "https://questionsmedicales.fr/author/Bridget%20B%20Matarazzo",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Sarra Nazem",
"url": "https://questionsmedicales.fr/author/Sarra%20Nazem",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Comprehensive profiling of cancer neoantigens from aberrant RNA splicing.",
"datePublished": "2024-05-15",
"url": "https://questionsmedicales.fr/article/38754917",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/jitc-2024-008988"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mitochondrial RNA Helicases: Key Players in the Regulation of Plant Organellar RNA Splicing and Gene Expression.",
"datePublished": "2024-05-17",
"url": "https://questionsmedicales.fr/article/38791540",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25105502"
}
},
{
"@type": "ScholarlyArticle",
"name": "The RNA helicase DDX39B activates FOXP3 RNA splicing to control T regulatory cell fate.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37261960",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7554/eLife.76927"
}
},
{
"@type": "ScholarlyArticle",
"name": "Structural basis for specific RNA recognition by the alternative splicing factor RBM5.",
"datePublished": "2023-07-15",
"url": "https://questionsmedicales.fr/article/37454201",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-023-39961-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "SEPT-GD: A decision tree to prioritise potential RNA splice variants in cardiomyopathy genes for functional splicing assays in diagnostics.",
"datePublished": "2022-10-18",
"url": "https://questionsmedicales.fr/article/36270459",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.gene.2022.146984"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Administration des services de santé",
"item": "https://questionsmedicales.fr/mesh/D006298"
},
{
"@type": "ListItem",
"position": 3,
"name": "Organisation et administration",
"item": "https://questionsmedicales.fr/mesh/D009934"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gestion du risque",
"item": "https://questionsmedicales.fr/mesh/D012308"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Gestion du risque - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Gestion du risque",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Gestion du risque",
"description": "Comment évaluer les risques en milieu hospitalier ?\nQuels indicateurs de risque surveiller ?\nQu'est-ce qu'une analyse de risque ?\nComment identifier les risques liés aux traitements ?\nQuel rôle joue le retour d'expérience ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=RNA+Splicing&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Gestion du risque",
"description": "Quels symptômes signalent un risque accru ?\nComment reconnaître une réaction indésirable ?\nQuels signes d'infection surveiller ?\nQuels symptômes d'une erreur médicamenteuse ?\nComment détecter une complication post-opératoire ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=RNA+Splicing&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Gestion du risque",
"description": "Quelles mesures préventives en milieu hospitalier ?\nComment sensibiliser le personnel aux risques ?\nQuel rôle des patients dans la prévention des risques ?\nComment prévenir les infections nosocomiales ?\nQuelles sont les stratégies de prévention des chutes ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=RNA+Splicing&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Gestion du risque",
"description": "Comment minimiser les risques lors des traitements ?\nQuel est l'impact des erreurs de médication ?\nComment gérer les risques liés à la chirurgie ?\nQuelles sont les stratégies de communication des risques ?\nComment évaluer l'efficacité des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=RNA+Splicing&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Gestion du risque",
"description": "Quelles complications peuvent survenir après une chirurgie ?\nComment gérer les complications liées aux traitements ?\nQuels sont les signes d'une complication grave ?\nComment prévenir les complications post-opératoires ?\nQuelles sont les complications des erreurs de médication ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=RNA+Splicing&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Gestion du risque",
"description": "Quels sont les facteurs de risque pour les infections ?\nComment identifier les facteurs de risque cardiovasculaires ?\nQuels comportements augmentent les risques de complications ?\nComment évaluer les facteurs de risque psychologiques ?\nQuels sont les facteurs de risque liés à l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D012308?mesh_terms=RNA+Splicing&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer les risques en milieu hospitalier ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des outils d'analyse des risques et des audits réguliers."
}
},
{
"@type": "Question",
"name": "Quels indicateurs de risque surveiller ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller les infections nosocomiales, les erreurs médicamenteuses et les chutes."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une analyse de risque ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est un processus systématique pour identifier et évaluer les risques potentiels."
}
},
{
"@type": "Question",
"name": "Comment identifier les risques liés aux traitements ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer les antécédents médicaux et les interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le retour d'expérience ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il permet d'apprendre des incidents passés pour améliorer la sécurité."
}
},
{
"@type": "Question",
"name": "Quels symptômes signalent un risque accru ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes tels que douleur thoracique, essoufflement ou confusion."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction indésirable ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller des signes comme éruptions cutanées ou gonflements après un traitement."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, rougeur, gonflement ou écoulement au site d'intervention."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une erreur médicamenteuse ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, vertiges ou changements d'état mental après la médication."
}
},
{
"@type": "Question",
"name": "Comment détecter une complication post-opératoire ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller des signes comme douleur intense, fièvre ou saignement."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives en milieu hospitalier ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Mettre en place des protocoles d'hygiène et de sécurité des patients."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le personnel aux risques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des formations régulières et des simulations de situations à risque."
}
},
{
"@type": "Question",
"name": "Quel rôle des patients dans la prévention des risques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients doivent être informés et impliqués dans leur propre soin."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections nosocomiales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Appliquer des protocoles stricts de désinfection et de stérilisation."
}
},
{
"@type": "Question",
"name": "Quelles sont les stratégies de prévention des chutes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer les risques individuels et adapter l'environnement des patients."
}
},
{
"@type": "Question",
"name": "Comment minimiser les risques lors des traitements ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des protocoles standardisés et former le personnel médical."
}
},
{
"@type": "Question",
"name": "Quel est l'impact des erreurs de médication ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent entraîner des complications graves et prolonger l'hospitalisation."
}
},
{
"@type": "Question",
"name": "Comment gérer les risques liés à la chirurgie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer les antécédents du patient et suivre des check-lists préopératoires."
}
},
{
"@type": "Question",
"name": "Quelles sont les stratégies de communication des risques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer les patients des risques et bénéfices des traitements proposés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des indicateurs de résultats cliniques et des retours des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une chirurgie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections, saignements, thromboses ou complications respiratoires."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux traitements ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller les patients et ajuster les traitements en fonction des symptômes."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une complication grave ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleur intense, fièvre élevée ou détérioration rapide de l'état général."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications post-opératoires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre des protocoles de soins post-opératoires et surveiller les patients."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications des erreurs de médication ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Réactions allergiques, surdosage ou échec thérapeutique."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les infections ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Âge avancé, immunodépression et interventions chirurgicales récentes."
}
},
{
"@type": "Question",
"name": "Comment identifier les facteurs de risque cardiovasculaires ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer l'hypertension, le diabète, le tabagisme et l'hypercholestérolémie."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent les risques de complications ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Tabagisme, sédentarité et mauvaise alimentation sont des comportements à risque."
}
},
{
"@type": "Question",
"name": "Comment évaluer les facteurs de risque psychologiques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Considérer l'anxiété, la dépression et le stress dans l'évaluation globale."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque liés à l'âge ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé augmente le risque de maladies chroniques et de complications."
}
}
]
}
]
}
Cancer neoantigens arise from protein-altering somatic mutations in tumor and rank among the most promising next-generation immuno-oncology agents when used in combination with immune checkpoint inhib...
First, SPLICE-neo was used to profile all DNA splice-site mutations in 11,892 tumors from The Cancer Genome Atlas (TCGA) and identified 11 profiles of splicing donor or acceptor site gains or losses. ...
We identified abundant splicing neoantigens in four representative TCGA cancers: BRCA, LUAD, LUSC, and LIHC. In addition to their substantial contribution to neoantigen load, several splicing neoantig...
SPLICE-neo is the first tool to comprehensively identify and prioritize splicing neoantigens from both DNA splice-site mutations and de novo RNA aberrant splicings. There are two major advances of SPL...
Mitochondrial genomes of land plants are large and exhibit a complex mode of gene organization and expression, particularly at the post-transcriptional level. The primary organellar transcripts in pla...
Genes associated with increased susceptibility to multiple sclerosis (MS) have been identified, but their functions are incompletely understood. One of these genes codes for the RNA helicase DExD/H-Bo...
The RNA-binding motif protein RBM5 belongs to a family of multi-domain RNA binding proteins that regulate alternative splicing of genes important for apoptosis and cell proliferation and have been imp...
Splice prediction algorithms currently used in routine DNA diagnostics have limited sensitivity and specificity, therefore many potential splice variants are classified as variants of uncertain signif...
We built the decision tree, SEPT-GD, by setting thresholds for the splice prediction programs implemented in Alamut. A set of 343 variants with known effects on splicing was used as control for sensit...
Compared to similar individually tested algorithms, SEPT-GD shows higher sensitivity (91 %) and comparable specificity (88 %) for both consensus (dinucleotides at the start and end of the intron, GT a...
SEPT-GD outperforms the tools commonly used for RNA splicing prediction and improves prioritisation of variants in cardiomyopathy genes for functional splicing analysis in a diagnostic setting....
Muscleblind-like splicing regulators (MBNLs) activate or repress the inclusion of alternative splicing (AS) events, enabling the developmental transition of fetal mRNA splicing isoforms to their adult...
Identification of cancer sub-types is a pivotal step for developing personalized treatment. Specifically, sub-typing based on changes in RNA splicing has been motivated by several recent studies. We t...
Alternative splicing (AS) is a dynamic RNA processing step that produces multiple RNA isoforms from a single pre-mRNA transcript and contributes to the complexity of the cellular transcriptome and pro...
Transfer RNAs (tRNAs) represent the most abundant class of RNA molecules in the cell and are key players during protein synthesis and cellular homeostasis. Aberrations in the extensive tRNA biogenesis...
During eukaryotic gene expression, alternative splicing of messenger RNA precursors is critical in increasing protein diversity and regulatory complexity. Multiple transcript isoforms could be produce...